These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 27257340

  • 1. Kangen-karyu raises surface body temperature through oxidative stress modification.
    Hirayama A, Okamoto T, Kimura S, Nagano Y, Matsui H, Tomita T, Oowada S, Aoyagi K.
    J Clin Biochem Nutr; 2016 May; 58(3):167-73. PubMed ID: 27257340
    [Abstract] [Full Text] [Related]

  • 2. Antioxidative effects related to the potential anti-aging properties of the Chinese prescription Kangen-karyu and Carthami Flos in senescence-accelerated mice.
    Satoh A, Yokozawa T, Cho EJ, Okamoto T, Sei Y.
    Arch Gerontol Geriatr; 2004 May; 39(1):69-82. PubMed ID: 15158582
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of the Chinese prescription Kangen-karyu against high glucose-induced oxidative stress in LLC-PK1 cells.
    Yokozawa T, Kim YA, Kim HY, Okamoto T, Sei Y.
    J Ethnopharmacol; 2007 Jan 03; 109(1):113-20. PubMed ID: 16949779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of the Chinese prescription Kangen-karyu and its crude drug Tanjin on ageing process in rats.
    Yokozawa T, Cho EJ, Okamoto T, Sei Y.
    J Pharm Pharmacol; 2006 Dec 03; 58(12):1591-9. PubMed ID: 17331322
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic efficacy of Kangen-karyu against H2O2-induced premature senescence.
    Cho EJ, Okamoto T, Yokozawa T.
    J Pharm Pharmacol; 2008 Nov 03; 60(11):1537-44. PubMed ID: 18957176
    [Abstract] [Full Text] [Related]

  • 10. The mechanisms underlying the anti-aging activity of the Chinese prescription Kangen-karyu in hydrogen peroxide-induced human fibroblasts.
    Satoh A, Yokozawa T, Kim YA, Cho EJ, Okamoto T, Sei Y.
    J Pharm Pharmacol; 2005 Oct 03; 57(10):1335-43. PubMed ID: 16259763
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective effect of Chinese prescription Kangen-karyu and its crude drug Tanjin against age-related lipidosis in rats.
    Cho EJ, Yokozawa T, Okamoto T.
    J Pharm Pharmacol; 2007 May 03; 59(5):687-94. PubMed ID: 17524234
    [Abstract] [Full Text] [Related]

  • 13. The protective role of Chinese prescription Kangen-karyu extract on diet-induced hypercholesterolemia in rats.
    Yokozawa T, Cho EJ, Sasaki S, Satoh A, Okamoto T, Sei Y.
    Biol Pharm Bull; 2006 Apr 03; 29(4):760-5. PubMed ID: 16595914
    [Abstract] [Full Text] [Related]

  • 14. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.
    Yamabe N, Kim HY, Kang KS, Zhao Q, Matsumoto K, Yokozawa T.
    J Ethnopharmacol; 2010 Jun 16; 129(3):299-305. PubMed ID: 20363309
    [Abstract] [Full Text] [Related]

  • 15. The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model.
    Yokozawa T, Kim HJ, Yamabe N, Okamoto T, Cho EJ.
    J Pharm Pharmacol; 2007 Sep 16; 59(9):1271-8. PubMed ID: 17883899
    [Abstract] [Full Text] [Related]

  • 16. Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes.
    Okamoto T, Park CH, Noh JS, Toriizuka K, Sei Y, Park JC, Yokozawa T.
    J Pharm Pharmacol; 2011 Jul 16; 63(7):952-9. PubMed ID: 21635261
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of Chinese prescription Kangen-karyu for dyslipi-demia, using 3T3-L1 adipocytes and type 2 diabetic mice.
    Hum Park C, Young Rhyu D, Sook Noh J, Min Park C, Yokozawa T.
    Drug Discov Ther; 2014 Jun 16; 8(3):121-31. PubMed ID: 25031044
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic potential of Chinese prescription Kangen-karyu for patient with lifestyle-induced metabolic syndrome.
    Park CH, Kitazawa T, Futamura A, Hirana H, Shoji M, Osanai M, Yokozawa T.
    Drug Discov Ther; 2020 Nov 04; 14(5):252-255. PubMed ID: 33116040
    [Abstract] [Full Text] [Related]

  • 19. A systematic review on anti-Alzheimer's disease activity of prescription Kangen-karyu.
    Paudel P, Park CH, Jung HA, Yokozawa T, Choi JS.
    Drug Discov Ther; 2020 May 06; 14(2):61-66. PubMed ID: 32336738
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Chinese prescription Kangen-karyu for patient with metabolic syndrome.
    Kitazawa T, Park CH, Hiratani K, Choi JS, Yokozawa T.
    Drug Discov Ther; 2020 Mar 08; 14(1):54-57. PubMed ID: 32115440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.